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The results of this study are the reported experiences of people suffering from COVID-19 
symptoms. This is not a peer-reviewed study. Data was analyzed by an experienced researcher 
and we invite any researchers interested in Survivor Corps data to contact us at 
HQ@survivorcorps.com. 
 
Survivor Corps is a grassroots movement connecting, educating and mobilizing COVID-19 
survivors with the medical, scientific and academic research community to help stem the tide of 
the pandemic and assist in the national recovery. 
 
Context: As businesses, doctors’ offices, and schools have reopened, many rely upon fever 
checks as a way of preventing people infected with COVID-19 from entering enclosed spaces 
where they could infect others. Fever checks do not detect the estimated 40% of people 
infected with COVID-19 who are asymptomatic.1 The question remains as to whether fever 
checks can identify the remaining 60% of people who do experience symptoms when they 
contract COVID-19. This is an important question because organizational decision-makers need 
an accurate and easy-to-implement method for identifying people who are contagious in order 
to prevent the spread of COVID-19 within their organizations and communities. 
 
Dr. Natalie Lambert at Indiana University School of Medicine and her research team 
collaborated with Survivor Corps to launch a detailed survey investigating COVID-19 survivors’ 
experiences with the disease. Participants answered questions about their medical history, 
underlying medical conditions, demographic information, the timing and severity of symptoms 
they experienced, the impact of COVID-19 on their health and mental wellness, and their 
experiences seeking medical treatment for COVID-19 health impacts. Survivors Corps’ founder, 
Diana Berrent, posted the link to the survey on the Survivor Corps Facebook Group and the link 
was shared with other online COVID-19 groups. This study is based on analysis of responses 
made by the 3,905 survey respondents who reported having symptomatic cases of COVID-19 
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Summary of Survey Findings: 
 
• The heavy reliance on fever checks in COVID-19 screening policies is an insufficient 
method of preventing the spread of the disease. Only 7.66% of survey respondents 
reported fever within the first 10 days of COVID-19 illness, the window in which people 
are most likely to be contagious.2 Since this analysis was of only symptomatic COVID-19 
survivors, most of whom were not hospitalized, the survey results suggest that only 
about 4.6% of all people infected with COVID-19 (symptomatic and asymptomatic cases 
of COVID-19) experience fever in the first 10 days of illness. 
• Fatigue (14.44%), cough (10.65%), headache (9.48%), shortness of breath or difficulty 
breathing (8.73%), inability to exercise or be active (8.02%), and changed sense of taste 
(7.71%) were all reported more frequently than fever (7.66%) during the first 10 days of 
COVID-19 illness. Updating screening policies to include the frequently reported early-
onset COVID-19 symptoms identified by this study would likely bolster efforts to stem 
further spread of the disease. 
• Our survey results indicate there is no single early-onset COVID-19 symptom that can 
act as an effective COVID-19 screening indicator. The CDC’s list of recommended COVID-
19 symptoms for self-screening assessment before entering clinics captures most of the 
frequently reported early-onset COVID-19 symptoms according to our survey. However, 
each individual symptom was reported by only a small percentage of individuals. The 
use of multiple indicators together as a screening tool is advisable. 
• The fact that people infected with COVID-19 experience such a wide array of symptoms 
means that symptom-based COVID-19 screening can never be done with the level of 
confidence that organizational decision-makers need to protect their members and 
communities. The development of high accuracy rapid COVID-19 tests, if they can be 
produced affordably and in large enough numbers, is the best solution for keeping 
businesses and schools open while protecting communities from the spread of COVID-
19. 
• The results of this study demonstrate the importance of conducting research with more 
representative populations of COVID-19 survivors, especially in terms of hospitalization 
status and demographics. Previous research of hospitalized COVID-19 patients found 
that fever is a common symptom, occurring at the onset of illness in an average of 63.43-
99%4 of hospitalized patients. Our study found that in our sample of mostly non-
hospitalized COVID-19 survivors, only 7.66% reported early-onset fever. COVID-19 
policies based on hospitalized patients’ experiences, such as with fever, may not address 
how COVID-19 manifests in the majority of those infected with the disease. 
 
Dr. Lambert and her research team collected and analyzed the survey responses. The results 
are broken down in the following figures:  
• Figure 1: Age of Survey Respondents  
• Figure 2: Race or Ethnicity of Respondents  
• Figure 3: Gender of Respondents 
• Figure 4: Respondent COVID-19 Diagnosis Method 
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• Figure 5: Percent of Respondents Reporting Each Symptom within First 10 days 
• Figure 6: Respondents Reporting Fever By Diagnosis Type 
• Figure 7: CDC Table of COVID-19 Symptoms That Are Common In Other Illnesses 
• Figure 8: CDC COVID-19 Symptom Self-screening Poster for Clinics 
• Figure 9: CDC Recommended COVID-19 Self-screening Symptoms (shaded) vs. % 
Respondents Reporting Each COVID-19 Symptom Occurring in First 10 Days of Illness 
Research summarizing studies of COVID-19 patients found that fever is a common symptom, 
occurring at the onset of illness in an average of 63.43-99%4 of hospitalized patients. However, 
the current hospitalization rate in the United States reported by the CDC is 178.2 per 100,000,5 
or .18%. People who are infected with COVID-19 but not ill enough to be hospitalized represent 
the vast majority of COVID-19 patients, but we have little official health data on these patients 
since most are encourage by their doctors to recover at home. People who are not ill enough to 
be hospitalized are also the group most likely to be entering public places while contagious. 
Fever screening is commonly used to keep customers, students, and patients infected with 
COVID-19 from entering a public space where they could infect others. However, we have little 
data about how common early-onset fever is for people who have mild to moderate cases of 
COVID-19. There is therefore a need for research of COVID-19 symptom presentation within a 
sample of COVID-19 survivors that is more representative of the general patient population. 
 
We created a research study that evaluates whether fever alone is an effective screening 
method for COVID-19. We asked the following research questions: 
 
1. During their most contagious period (the first 10-days after onset of symptoms2), how 
commonly do COVID-19 survivors report having a fever? 
2. If fever is not a good indicator that someone with COVID-19 is infectious, what symptoms 
are better indicators? 
 
Method: To answer these questions, Dr. Natalie Lambert and her research team at Indiana 
University School of Medicine collaborated with Survivor Corps to conduct an IRB-approved 
survey of people experiencing COVID-19 symptoms. Anyone experiencing COVID-19 symptoms 
and over the age of 18 was eligible to participate. A link to the survey was posted on the 
Survivor Corps Facebook page and website as well as several other COVID-19 online groups. The 
study was advertised through these groups with the goal of recruiting as many non-hospitalized 
participants as possible. The survey was complete by 3,963 participants; 89.94% reported never 
being hospitalized during their illness, 14.44% reported being hospitalized, and 0.61% reported 
“other.” 58 respondents did not report symptoms and were removed from the dataset, 
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Figures 1-3 show participants’ demographics. 
 
Figure 4 shows the COVID-19 diagnosis methods reported by participants: 48.91% reported a 
positive test, 27.27% reported diagnosis by a doctor, 19.15% reported self-diagnosis from 
symptoms, and 4.66% reported “other.” 
 
Figure 5 reports the number and percentage of respondents who reported each symptom 
during their 10-day infectious window, thereby indicating which symptoms could be useful 
screening indicators for COVID-19. Survey participants reported each COVID-19 symptom they 
experienced along with information about how many days after the onset of COVID-19 each 
symptom began. Using these data points, we calculated how often each symptom was reported 
to occur within a 10-day window from participants’ onset of symptoms (the period when they 
were most likely to be contagious). 
 
For Figure 6 we calculated the diagnosis method for all respondents who reported fever. 
Results show that the most common method of COVID-19 diagnosis for people who had fever 
was via a positive COVID-19 test (40.8%), followed by diagnosis by a doctor (35.12%), self-
diagnosis from symptoms (20.07%), and other (4.01%). This is very similar to the proportions of 
diagnosis method for all symptoms. 
 
Figure 7 is a chart from the CDC’s website which compares symptoms of common illnesses 
(strep throat, the common cold, flu, asthma, and allergies) to the symptoms of COVID-19. We 
used this to determine which early-onset COVID-19 symptoms found by our study are unique 
compared to the symptoms other common illnesses  
 
Figure 8 is a poster developed by the CDC encouraging COVID-19 multi-symptom self-screening 
at medical clinics. 
 
Finally, in Figure 9 we compared the screening symptoms listed on the CDC’s poster in Figure 9 
to the early-onset symptoms identified by this study to evaluate whether the CDC list captures 
the most frequent early-onset COVID-19 symptoms according to the results of this study. 
 
Interpretation of Findings: Of the 3,905 survey respondents, 1,512 (38.7%) reported 
experiencing fever or chills. However, only 299 (7.66%) respondents reported that they had 
fever or chills within the first 10 days of illness. It is important to remember that the results of 
our study only represent the approximate 60% of people who are symptomatic, meaning they 
experience COVID-19 symptoms. An additional 40% of the population is thought to have COVID-
19 but experience no symptoms. They are however able to infect others during their contagious 
period. Using these assumptions,1 if 7.66% of symptomatic COVID-19 survivors report fever in 
the first 10 days, that would amount to only 4.6% of the total population of people infected 
with COVID-19 (symptomatic and asymptomatic combined) having fever during the first 10 days 
of illness (.0766 X 60 = 4.6 out of 100). In other words, if 100 people are infected with COVID-
19, an average of 95.4 of them would pass a fever check and unknowingly pass along the virus 
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to others. Therefore, based on the evidence resulting from this study, fever is not a good 
indicator that people with mild to moderate cases of COVID-19 are contagious. 
 
Analysis of study participants shows that fatigue (14.44%), cough (10.65%), headache (9.48%), 
shortness of breath or difficulty breathing (8.73%), inability to exercise or be active (8.02%), and 
changed sense of taste (7.71%) were all reported more frequently than fever (7.66%). In the 
survey, 101 symptoms identified as COVID-19 symptoms through official health information 
sources and our previous research6 were provided to participants. Only 2 of these symptoms, 
fatigue and cough, were reported by more than 10% of respondents as occurring in the first 10 
days of illness. These results suggest that no one symptom is a clear indicator of the infectious 
stage of COVID-19. 
 
How frequently a symptom occurs during the first 10 days of COVID-19 illness onset is not the 
only information we can use to identify useful COVID-19 screening symptoms. We should also 
consider which early-onset COVID-19 symptoms are unique to COVID-19 and are not typically 
present in other illnesses. Figure 8 is a chart from the CDC’s website which compares symptoms 
of common illnesses (strep throat, the common cold, flu, asthma, and allergies) to the 
symptoms of COVID-19. Common COVID-19 symptoms found by this study that are unique 
compared to other common illnesses are: headache, shortness of breath or difficulty breathing, 
inability to exercise or be active, changed sense of taste, abdominal pain, and difficulty 
concentrating or focusing. In particular, shortness of breath or difficulty breathing, experienced 
by a patient with no history of asthma, could be a good indicator of COVID-19 infection. 
 
Finally, we compared the results of our survey to the set of COVID-19 symptoms recommended 
by the CDC for use in self-screening of COVID-19 infection prior to entering a clinic (Figures 9-
10). The CDC list captures the majority of the most frequently reported early-onset COVID-19 
symptoms found in our survey. However, the results of our study demonstrate that we cannot 
consider any one of these symptoms alone to be a reliable or definitive screening tool since 
each individual symptom was reported by only a small percentage of individuals.  
 
Without access to rapid COVID-19 tests, the results of our survey indicate that health policies 
preventing people who exhibit any symptom of illness from entering buildings are the most 
effective method for preventing the spread of COVID-19. However, such a strict and broad 
health policy would come at the cost of disruption of business and school activities. In addition, 
it would likely keep people who need health scans and medical treatment from accessing 
essential care.  
 
Updating screening policies to incorporate both frequently occurring, early-onset COVID-19 
symptoms (fatigue and cough) as well as symptoms unique to COVID-19 (headache, shortness 
of breath or difficulty breathing, inability to exercise of be active, changed sense of taste, 
abdominal pain, and difficulty concentrating or focusing) will help to increase the accuracy of 
symptom-based screening methods. However, the fact that people infected with COVID-19 
experience such a wide array of symptoms indicates that symptom-based COVID-19 screening 
can never be done with the level of confidence that organizational decision-makers need to 
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protect their communities. Recent research has found that people who eat at restaurants are 
twice as likely to contract COVID-19,7 which is a strong warning against having false confidence 
in fever and other symptom-based COVID-19 screening. Reliable, affordable, and plentiful rapid 
COVID-19 tests would offer a necessary solution to this problem. 
 
Dr. Lambert’s and Survivor Corps’ research with long haulers and non-hospitalized COVID-19 
patients has found that COVID-19 survivors’ experiences often do not match official health 
information. Many of the people who took our survey are suffering from Long Term Covid-19 
(LTC-19), a condition where COVID-19 health complications persist for many weeks or months 
after initial infection. The broad range of COVID-19 experiences are not well researched or 
understood and therefore are not well represented in health policy. This study of early-onset 
symptoms suggests that there may be other ways in which COVID-19 is experienced differently 
by hospitalized and non-hospitalized COVID-19 survivors, and we are working to investigate 
other factors that may be sources of these different experiences such as COVID-19 survivors’ 
underlying health conditions, medical history, demographics, and socioeconomic status. 
 
COVID-19 survivors are participating in research studies in huge numbers to help researchers 
answer important questions about COVID-19. These survivors are frustrated by their LTC-19 
challenges and the medical community’s nascent understanding of the disease and its 
consequences. Funding is needed to scale up essential research efforts. This funding must be 
dedicated to patient-focused research, as well as research that can help create effective COVID-
19 health policies. Organizations like Survivor Corps are bringing COVID-19 stakeholders such as 
medical doctors, researchers, industry, policy makers, and COVID-19 survivors together, but we 
need financial support and commitment on par with that being given to Operation Warp Speed 
towards the development of a COVID-19 vaccine. A vaccine is an essential component to 
beating this pandemic, but we cannot ignore the need to implement better preventative 
policies to curb the spread of the disease, develop therapies that halt the damage COVID-19 
does to the body early its progression, and help heal the hundreds of thousands of patients 
who are struggling to recover from LTC-19. Focused research designed to prevent the spread of 
COVID-19 and help heal the many COVID-19 survivors suffering from long-term health impacts 
must be a part of our country’s recovery strategy.  
*** 
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Figure 5. Percent of Respondents Reporting Each Symptom within First 10 days 
 
Symptom 
# Total Respondents Who 
Reported Experiencing This 
Symptom Within First 10 
Days of Illness 
% Total Respondents Who 
Reported Experiencing This 
Symptom Within First 10 
Days of Illness 
fatigue 564 14.44 
cough 416 10.65 
headache 370 9.48 
shortness of breath or difficulty 
breathing 341 8.73 
inability to exercise or be active 313 8.02 
changed sense of taste 301 7.71 
fever or chills 299 7.66 
diarrhea 279 7.14 
abdominal pain 259 6.63 
difficulty concentrating or focusing 258 6.61 
muscle or body aches 247 6.33 
partial or complete loss of sense of smell 234 5.99 
congested or runny nose 219 5.61 
sleeping more than normal 215 5.51 
bone aches in extremities 212 5.43 
difficulty sleeping 211 5.40 
partial or complete loss of sense of taste 204 5.22 
sore throat 193 4.94 
chills but no fever 186 4.76 
anxiety 184 4.71 
persistent chest pain or pressure 180 4.61 
dizziness 171 4.38 
nausea or vomiting 165 4.23 
confusion 154 3.94 
night sweats 150 3.84 
heart palpitations 132 3.38 
joint pain 125 3.20 
changing symptoms 121 3.10 
memory problems 107 2.74 
tachycardia 103 2.64 
constant thirst 102 2.61 
shortness of breath or exhaustion from 
bending over 102 2.61 
arrhythmia 97 2.48 
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blurry vision 93 2.38 
weight loss 92 2.36 
phlegm in back of throat 89 2.28 
brain pressure 82 2.10 
cold burning feeling in lungs 79 2.02 
low blood oxygen 76 1.95 
low temperature 74 1.90 
feeling irritable 72 1.84 
lower back pain 71 1.82 
burning sensations 69 1.77 
clogged ears 65 1.66 
sadness 65 1.66 
ear pain or ear ache 64 1.64 
dry throat 60 1.54 
post nasal drip 60 1.54 
extreme pressure at base of head or 
occipital nerve 59 1.51 
dry eyes 52 1.33 
heat intolerance 52 1.33 
calf cramps 50 1.28 
sharp or sudden chest pain 48 1.23 
cracked or dry lips 47 1.20 
mid-back pain at base of ribs 47 1.20 
neck muscle pain 47 1.20 
neuropathy in hands and feet 47 1.20 
tremors 47 1.20 
costochondritis 44 1.13 
feeling of burning skin 40 1.02 
phantom smells 40 1.02 
swollen lymph nodes 40 1.02 
reflux 38 0.97 
tinnitus 38 0.97 
upper back pain 37 0.95 
rash 36 0.92 
hand or wrist pain 31 0.79 
nerve sensations 31 0.79 
bilateral neck throbbing around lymph 
nodes 29 0.74 
muscle twitching 29 0.74 
high blood pressure 27 0.69 
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covid toes 26 0.67 
floaters or flashes of light in vision 23 0.59 
mouth sores or sore tongue 23 0.59 
eye stye or infection 22 0.56 
foot pain 22 0.56 
hot blood rush 20 0.51 
swollen hands or feet 20 0.51 
jaw pain 19 0.49 
kidney pain 19 0.49 
spikes in blood pressure 19 0.49 
painful scalp 18 0.46 
GERD with excessive salivation 16 0.41 
low blood pressure 15 0.38 
dry or peeling skin 14 0.36 
irregular or skipped menstrual cycles 14 0.36 
syncope 12 0.31 
uti (urinary tract infection) 12 0.31 
weight gain 12 0.31 
bulging veins 11 0.28 
kidney issues or protein in urine 11 0.28 
thrush 11 0.28 
goiter or lump in throat 10 0.26 
menstrual cycles that are heavier or 
lighter than usual 9 0.23 
herpes 8 0.20 
hair loss 7 0.18 
personality change (drastic) 6 0.15 
anemia 5 0.13 
dry scalp or dandruff 4 0.10 
hormone imbalances 4 0.10 
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Figure 7. CDC Table of COVID-19 Symptoms That Are Common In Other Illnesses 
 
Source: https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/symptom-
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Figure 8. CDC COVID-19 Symptom Self-screening Poster for Clinics 
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Figure 9. CDC Recommended COVID-19 Self-screening Symptoms (shaded) vs. % Respondents 














































persistent chest pain or pressure
anxiety
chills but no fever
sore throat
partial or complete loss of sense of taste
difficulty sleeping
bone aches in extremities
sleeping more than normal
congested or runny nose
partial or complete loss of sense of smell
muscle or body aches




changed sense of taste
inability to exercise or be active




CDC Recommended COVID-19 Screening Symptoms (shaded) vs. % 
Respondents Reporting Most Common COVID-19 Symptoms Occurring in 
First 10 Days of Illness
